U.S. Insomnia Therapies Markets

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

This research service analyzes the changing dynamics within the U.S. insomnia therapies market. Included in this research service are revenue forecasts, market shares, patient forecasts, market and technology trends, factors affecting market growth, major issues and challenges, pricing trends, and product analysis. The market is segmented by product class - benzodiazepines, sedating antidepressants, non-benzodiazepines, and emerging therapies. This research service discusses the current and future market landscape, critically evaluates each major product, and highlights the window of opportunities in this fledgling market.

Table of Contents

U.S. Insomnia Therapies Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Insomnia Therapies Markets, Total MarketOverviewScope and SegmentationResearch MethodologyIntroductionMarket and Technology TrendsMarket DynamicsDemand AnalysisPatient ForecastsRevenue ForecastsIndustry Issues and ChallengesCompetitive LandscapeCompetitive StructurePipeline AnalysisMarket Share AnalysisFrost & Sullivan AwardsProduct Value Enhancement of the Year AwardSpecialty Product of the Year AwardIndustry Innovation and Advancement of the Year AwardCompany of the Year AwardU.S. Insomnia Therapies Markets, Benzodiazepines MarketSegment HighlightsSegment HighlightsOverviewIntroductionMarket Engineering AnalysisSegment IssuesMarket Forecasts and TrendsRevenue ForecastsPatient ForecastsFactors Affecting Market GrowthProduct AnalysisPricing TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisU.S. Insomnia Therapies Markets, Sedating Antidepressants MarketSegment HighlightsSegment HighlightsOverviewIntroductionMarket Engineering AnalysisSegment IssuesMarket Forecasts and TrendsRevenue ForecastsPatient ForecastsFactors Affecting Market GrowthProduct AnalysisPricing TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisU.S. Insomnia Therapies Markets, Non-Benzodiazepines MarketSegment HighlightsSegment HighlightsOverviewIntroductionMarket Engineering AnalysisSegment IssuesMarket Forecasts and TrendsRevenue ForecastsPatient ForecastsFactors Affecting Market GrowthProduct AnalysisPricing TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisU.S. Insomnia Therapies Markets, Emerging Therapies MarketSegment HighlightsSegment HighlightsOverviewIntroductionMarket Engineering AnalysisSegment IssuesMarket Forecasts and TrendsRevenue ForecastsPatient ForecastsProduct AnalysisU.S. Insomnia Therapies Markets, AppendixDecision Support DatabaseDrugs in Clinical TrialsChronic InsomniaEconomic CostsNeurologists and PsychiatristsAlcoholic Population




Related Research

Release Date : 18-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Release Date : 15-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.